Targeting the Inflammasome to Treat ANCA Associated Glomerulonephritis

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1075304

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Anti neutrophil cytoplasmic antibody (ANCA) vasculitis is a type of kidney disease which causes significant morbidity and mortality in the Australian population. Current treatments are toxic and are associated with significant side-effects. This research focusses on a pathway of immune activation which is of emerging importance, called the inflammasome, which may be a target for future therapies in this disease.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2017

Funding Scheme: Postgraduate Scholarships

Funding Amount: $122,686.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

autoimmunity | glomerulonephritis | renal disease | renal failure | vasculitis

Related Links